Fulgent Genetics, Inc. (FLGT): Margin dodolan resik

Net profit margin demonstrates the efficiency of Fulgent Genetics, Inc., where the indicator stands at -27.50. Physicians value the brand for its high-precision genetic testing and speed. The business is currently focusing on oncology diagnostics to avoid dumping in the mass market segment. Growth relies on cloud services and the reduction of testing costs to drive global expansion.
Fulgent Corp (FLGT) - rincian metrik lan laporan keuangan

This indicator measures the share of net income in total revenue, allowing investors to assess the actual efficiency of converting revenue into final capital. By analyzing the net profit margin, one can see how the strategic pivot of Fulgent Genetics, Inc. (FLGT) toward oncogenetics and therapeutic solutions, supported by significant cash reserves, impacts operational profitability and business resilience.